148962-93-0 Usage
Uses
Used in Pharmaceutical Synthesis:
(cis)-2-(4-phenylcyclohexyl)acetic acid is used as a key intermediate in the synthesis of various pharmaceuticals due to its unique structure and reactivity. Its ability to form derivatives and participate in chemical reactions makes it a promising candidate for the development of new drugs and medications.
Used in Drug Development:
(cis)-2-(4-phenylcyclohexyl)acetic acid's potential applications extend to the field of medicine and drug development, where its structural properties can be leveraged to create novel therapeutic agents. Researchers can explore its interactions with biological targets and its potential to modulate specific pathways, which could lead to the discovery of new treatments for various diseases.
Used in Industrial Product Manufacturing:
In addition to its pharmaceutical applications, (cis)-2-(4-phenylcyclohexyl)acetic acid may also find use in the manufacturing of various industrial products and materials. Its chemical properties could be harnessed for the production of specialty chemicals, additives, or components in the chemical, plastics, or coatings industries.
Check Digit Verification of cas no
The CAS Registry Mumber 148962-93-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,8,9,6 and 2 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 148962-93:
(8*1)+(7*4)+(6*8)+(5*9)+(4*6)+(3*2)+(2*9)+(1*3)=180
180 % 10 = 0
So 148962-93-0 is a valid CAS Registry Number.
148962-93-0Relevant academic research and scientific papers
IMMUNOREGULATORY AGENTS
-
Paragraph 0317; 0318, (2016/01/27)
Compounds that modulate the oxidoreductase enzyme indoleamine 2,3-dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided.
